Stance Capital’s CVS Health CVS Stock Holding History

Stance Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-39,048	Closed	-$3.1M	–	290
2025 Q4	$3.1M	Buy	+39,048	New	+$3.08M	1.14%	23
2025 Q3	–	Sell	-28,910	Closed	-$1.99M	–	286
2025 Q2	$1.99M	Buy	+28,910	New	+$1.9M	0.75%	38

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stance Capital's CVS Position: Q1 2026 in Review

Stance Capital sold out of CVS Health (CVS) in Q1 2026, closing a stake of 39,048 shares — an estimated $3.1M sold.

Stance Capital first reported a position in CVS in Q2 2025 and held it in 2 quarters. The position peaked at $3.1M in Q4 2025. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Stance Capital reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Stance Capital sold 39,048 CVS Health shares in Q1 2026, an estimated $3.1M.
Stance Capital first reported a position in CVS Health in Q2 2025 and held it in 2 quarters.
Stance Capital's CVS Health position peaked at $3.1M in Q4 2025.
1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.